Učitavanje...
Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?
SIMPLE SUMMARY: Adrenocortical carcinoma is a rare but aggressive malignancy with poor outcomes even for patients with early-stage disease. Several immunotherapy clinical trials, many of which are still in progress, have yielded modest results so far. In-depth understanding of the tumor microenviron...
Spremljeno u:
| Izdano u: | Cancers (Basel) |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8069982/ https://ncbi.nlm.nih.gov/pubmed/33918733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081798 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|